Brainsway (NASDAQ:BWAY) versus Sunny Optical Technology (Group) (OTCMKTS:SNPTF) Head to Head Survey

Brainsway (NASDAQ:BWAY) and Sunny Optical Technology (Group) (OTCMKTS:SNPTF) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their profitability, valuation, risk, dividends, institutional ownership, analyst recommendations and earnings.

Volatility and Risk

Brainsway has a beta of 1.23, indicating that its stock price is 23% more volatile than the S&P 500. Comparatively, Sunny Optical Technology (Group) has a beta of 0.78, indicating that its stock price is 22% less volatile than the S&P 500.

Valuation & Earnings

This table compares Brainsway and Sunny Optical Technology (Group)”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Brainsway	$52.22 million	13.16	$7.57 million	$0.25	68.68
Sunny Optical Technology (Group)	$5.33 billion	1.63	$375.45 million	N/A	N/A

Sunny Optical Technology (Group) has higher revenue and earnings than Brainsway.

Insider & Institutional Ownership

30.1% of Brainsway shares are owned by institutional investors. 19.0% of Brainsway shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Profitability

This table compares Brainsway and Sunny Optical Technology (Group)’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Brainsway	14.62%	11.10%	6.97%
Sunny Optical Technology (Group)	N/A	N/A	N/A

Analyst Ratings

This is a summary of recent ratings and price targets for Brainsway and Sunny Optical Technology (Group), as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Brainsway	0	0	3	1	3.25
Sunny Optical Technology (Group)	0	0	0	0	0.00

Brainsway presently has a consensus target price of $15.00, suggesting a potential downside of 12.64%. Given Brainsway’s stronger consensus rating and higher possible upside, equities analysts clearly believe Brainsway is more favorable than Sunny Optical Technology (Group).

Summary

Brainsway beats Sunny Optical Technology (Group) on 11 of the 13 factors compared between the two stocks.

About Brainsway

BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson's diseases. The company serves doctors, hospitals, and medical centers in the field of psychiatry. BrainsWay Ltd. was founded in 2003 and is headquartered in Jerusalem, Israel.

About Sunny Optical Technology (Group)

Sunny Optical Technology (Group) Company Limited, an investment holding company, engages in designing, researching, developing, manufacturing, and selling optical and optical related products, and scientific instruments. The company's Optical Components segment offers glass spherical and aspherical lenses, handset lens sets, vehicle lens sets, security surveillance lens sets, and other lens sets. Its Optoelectronic Products segment comprise handset camera modules, three dimensional optoelectronic products, vehicle modules, and other optoelectronic modules. The company's Optical Instruments segment includes microscopes and intelligent inspection equipment for testing. Its optoelectronic-related products are used in handsets, digital cameras, vehicle imaging and sensing systems, security surveillance systems, virtual reality/augmented reality, and robots, which are combined with optical, electronic, algorithm, and mechanical technologies. In addition, the company engages in the research and development of infrared and semiconductor technologies; trading of optical instruments and optoelectronics products; property leasing activities; and development, service, and consultation of technology; provision of financing services; and import and export agency services. It operates primarily in the People's Republic of China, rest of Asia, Europe, North America, and internationally. The company was founded in 1984 and is headquartered in Yuyao, China.